Direct Answer

Medtronic reported revenue of $36.4 billion for the fiscal year ended April 24, 2026, with an operating margin of 17.8% and net income of $4,801, according to its SEC filings. Revenue grew 8.4% from the prior year.

What Are Medtronic's Key Financial Figures?

Fiscal yearFY2026
ended April 24, 2026
FY2025
ended April 25, 2025
FY2024
ended April 26, 2024
FY2023
ended April 28, 2023
Revenue$36.4 billion$33.5 billion$32.4 billion$31.2 billion
Operating income$6.5 billion$6.0 billion$5.1 billion$5.5 billion
Operating margin17.8%17.8%15.9%17.6%
Net income$4,801$4,662$3,676$3,758
Net margin0.0%0.0%0.0%0.0%
Operating cash flow$7.3 billion$7.0 billion$6.8 billion$6.0 billion
Capital expenditures$1.9 billion$1.9 billion$1.6 billion$1.5 billion
Free cash flow$5.4 billion$5.2 billion$5.2 billion$4.6 billion

Operating margin held roughly steady between fiscal 2025 and 2026, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $5.4 billion against net income of $4,801; cash generation covered reported earnings.

Bar chart of Medtronic revenue, operating income, net income for fiscal 2023 to 2026. In fiscal 2026, revenue was $36.4 billion, operating income $6.5 billion and net income $4,801.
Medtronic revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.
Line chart of Medtronic operating margin and net margin for fiscal 2023 to 2026. In fiscal 2026, operating margin was 17.8% and net margin was 0.0%.
Medtronic operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.
Bar chart of Medtronic operating cash flow, capital expenditures, free cash flow for fiscal 2023 to 2026. In fiscal 2026, operating cash flow was $7.3 billion, capital expenditures was $1.9 billion, free cash flow was $5.4 billion.
Medtronic operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.

What Does Medtronic's Balance Sheet Show?

Cash and cash equivalents$1.9 billion
Long-term debt$26.2 billion
Total assets$93.0 billion
Total liabilities$43.0 billion
Shareholders' equity$49.5 billion
Current ratio2.1x

Balance sheet values are as of the end of fiscal 2026. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.

Where These Numbers Come From

Every figure on this page is a value Medtronic reported in its own SEC filings, read from the SEC's XBRL data (accession 0001628280-26-044354 for fiscal year 2026). Ratios are computed from those reported values. Figures were retrieved on October 12, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.

Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.

Frequently Asked Questions

What was Medtronic's revenue in fiscal 2026?

Medtronic reported revenue of $36.4 billion for the fiscal year ended April 24, 2026, according to its SEC filings.

What is Medtronic's operating margin?

Medtronic's operating margin was 17.8% in fiscal 2026: operating income of $6.5 billion on revenue of $36.4 billion.

How much free cash flow did Medtronic generate?

Operating cash flow of $7.3 billion less capital expenditures of $1.9 billion gives free cash flow of $5.4 billion for fiscal 2026.

References

Related Pages